Psylo in the AFR Magazine

Psylo CEO Josh Ismin was interviewed for the Australian Financial Review Magazine feature on microdosing

Previous
Previous

Psylo Newsletter - March 2022

Next
Next

Why microdosing is gaining momentum in Australia